Prakiraan pendapatan perusahaan Longboard Pharmaceuticals Inc (LBPH)

Simbol resmi perusahaan longboardpharma.com (LBPH)

The development of drugs for rare brain pathologies is limited by strict FDA oversight and capital intensity, which has become the primary trigger for the market. GURU.Markets quotes form this chart, where the sales forecast for Longboard Pharmaceuticals (LBPH) demonstrates investor reaction, and the value of 0.00 captures this metric. The business foundation relies on CNS innovations and the delegation of trials to external CRO partners.

LBPH - Prakiraan pendapatan perusahaan longboardpharma.com ing rentang 04.07.2022 - 07.12.2024

Longboard Pharma - rincian analitis lan metrik utama (LBPH)

Pambiji fundamental:longboardpharma.com
Produk mawa merek Longboard Pharmaceuticals Inc

Analyzing future cash flows is critical for assessing an issuer's financial stability during screening. This metric recalculates expected revenue daily, transforming discrete reporting into a continuous indicator of market reliability. For Longboard Pharmaceuticals (LBPH), this calculation confirms the capitalization of bexicaserin patents and the success of clinical trials. By analyzing the company's future sales vector, an investor determines the business's ability to maintain asset value. A stable upward trend confirms the strengthening of its competitive advantage.

Analisis perusahaan pesaing

Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Prakiraan volume dodolan|XENE - Prakiraan volume dodolan|VKTX: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Prakiraan volume dodolan|DNLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan harmonybiosciences.com (HRMY)|Biohaven - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan AMLX (amylyx.com)|Trevi Pharma (TRVI) - Volume dodolan sing dikarepake perusahaan|Praxis Corp - Prakiraan volume dodolan|Anavex Corp (AVXL) - Volume dodolan mangsa ngarep perusahaan|CBLL: Prakiraan volume dodolan|Prothena Biosciences - Pendapatan mangsa ngarep perusahaan|ALEC (alector.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANNX (Annexon Biosciences)|Prakiraan pendapatan perusahaan Omeros Corporation (OMER)|Neurogene Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan AC Immune S.A. ACIU|Dodolan mangsa ngarep perusahaan Voyager Therapeutics (VYGR)|Neumora - Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SCLX|Tevogen Bio Inc. (TVGN) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan ACOG|CGTX (cogrx.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan inhibikase.com (IKT)|Prakiraan pendapatan perusahaan Cassava Sciences Inc (SAVA)|Dodolan mangsa ngarep perusahaan Assertio|Prakiraan volume dodolan COYA (Coya Therapeutics, Inc.)|Prakiraan volume pendapatan perusahaan VTGN (VistaGen Therapeutics Inc)|OVID: Volume dodolan mangsa ngarep perusahaan|ABOS: Prakiraan pendapatan perusahaan|CervoMed (CRVO) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PEPG (PepGen)|Volume dodolan mangsa ngarep perusahaan JUNS (Jupiter Neurosciences, Inc.)|Prakiraan volume dodolan relmada.com (RLMD)|Prakiraan pendapatan perusahaan Annovis Bio Corp ANVS|GRCE: Prakiraan pendapatan perusahaan|AIFF - Prakiraan pendapatan perusahaan|KLTO (anewmeds.com) - Prakiraan pendapatan perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Volume dodolan mangsa ngarep perusahaan|revivapharma.com - Pendapatan mangsa ngarep perusahaan|MTVA (metaviatx.com) - Prakiraan volume dodolan|NRXS: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan HSDT|PASG - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan NEUP (Neuphoria Therapeutics)|NERV: Prakiraan pendapatan perusahaan|ATHA: Volume dodolan mangsa ngarep perusahaan|Addex Therapeutics Ltd - Prakiraan volume pendapatan perusahaan|Alzamend Neuro, Inc. (ALZN) - Prakiraan pendapatan perusahaan|CYCN (Cyclerion Therapeutics Inc.) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan PTIX|KTTA: Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Brainstorm Cell Therapeutics, Inc. BCLI|Pendapatan mangsa ngarep perusahaan CARA|chromocell.com - Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan ELYM|ITCI: Prakiraan volume dodolan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics